造血干细胞移植对患者感知的生活质量的影响:一项纵向研究
Pablo Ortolá-Alonso1, Enric Santacatalina-Roig1,2, Elena Chover-Sierra1,3,4
1Nursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.
Nursing reports (Pavia, Italy)
|January 22, 2024
概括
造血干细胞移植最初会降低生活质量,但在一年内就会恢复. 社会人口统计学因素影响患者在这种强化癌症治疗后报告的结果.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 移植医学 移植医学
背景情况:
- 造血干细胞移植 (HSCT) 是对瘤血液学疾病的关键治疗方法.
- 在HSCT后评估长期生活质量 (QoL) 对于患者的康复和护理至关重要.
研究的目的:
- 评估HSCT后长达两年内患有瘤血液学疾病的成年患者的生活质量.
- 为了确定在移植后期影响QoL变化的因素.
主要方法:
- 一项量化,观察性,纵向性研究,涉及121名接受HSCT的患者.
- 使用功能性评估癌症治疗 - 骨髓移植 (FACT-BMT) 问卷及其子尺度来评估生活质量.
- 计划进行为期2年的随访,39名参与者完成了这项研究.
主要成果:
- 医院出院时的QoL最初下降,随后在HSCT后的一年内逐渐改善.
- 在整个研究中,男性参与者报告的QoL得分明显高于女性.
- 住院时间长度对身体和功能健康有负面影响;婚姻状况也与QOL感知相关.
结论:
- 患者在HSCT后一年恢复了基线QoL水平,尽管最初的下降.
- 社会人口统计学变量对患者在HSCT后如何感知他们的QOL起着作用.
- 建议使用更大的样本大小进行进一步的研究,以获得更强大的发现.
相关概念视频
Bone Marrow Sampling and Transplants
332
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Tissue Transplantation
372
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
372


